The development of flavivirus vaccines

被引:0
|
作者
Pulmanausahakul, Rojjanaporn [1 ]
Khakpoor, Atefeh [1 ]
Smith, Duncan R. [1 ]
机构
[1] Mahidol Univ, Inst Mol Biosci, Bangkok 10700, Thailand
来源
AFRICAN JOURNAL OF BIOTECHNOLOGY | 2010年 / 9卷 / 04期
关键词
Attenuation; fever; encephalitis; flavivirus; hemorrhagic; vaccine; WEST-NILE-VIRUS; LIVE-ATTENUATED VACCINE; JAPANESE ENCEPHALITIS; YELLOW-FEVER; NEUTRALIZING ANTIBODIES; PROTECTIVE IMMUNITY; RECOMBINANT SUBUNIT; DENGUE; IMMUNIZATION; CANDIDATE;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mosquito and tick-borne flaviviruses are the causative agents of some of the world's most important diseases, including dengue fever, yellow fever, Japanese encephalitis, tick-borne encephalitis and West Nile fever. Cumulatively, these viruses cause many millions of infections each year and impose a significant burden on public health resources, particularly in developing and newly developed countries. Vaccine development to eliminate flaviviral infections has been marked by uneven progress and a large number of setbacks. To date, no single approach has proved successful in leading to vaccine development against a wide range of flaviviruses, but the application of modern techniques to the problem is opening up new avenues of approach. This review summarizes some of the developments in vaccine research aimed at inducing protective immunity against flaviviral infections.
引用
收藏
页码:409 / 415
页数:7
相关论文
共 50 条
  • [1] Research and Development of Chimeric Flavivirus Vaccines
    Delagrave, Simon
    Guirakhoo, Farshad
    [J]. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIH, VOL 1: FRONTIERS IN RESEARCH, 2008, : 459 - 471
  • [2] FLAVIVIRUS VACCINES
    STEPHENSON, JR
    [J]. VACCINE, 1988, 6 (06) : 471 - 480
  • [3] Flaviviruses and flavivirus vaccines
    Heinz, Franz X.
    Stiasny, Karin
    [J]. VACCINE, 2012, 30 (29) : 4301 - 4306
  • [4] Recombination and flavivirus vaccines: a commentary
    Monath, TP
    Kanesa-thasan, N
    Guirakhoo, F
    Pugachev, K
    Almond, J
    Lang, J
    Quentin-Millet, MJ
    Barrett, ADT
    Brinton, MA
    Cetron, MS
    Barwick, RS
    Chambers, TJ
    Halstead, SB
    Roehrig, JT
    Kinney, RM
    Rico-Hesse, R
    Strauss, JH
    [J]. VACCINE, 2005, 23 (23) : 2956 - 2958
  • [5] Current status of flavivirus Vaccines
    Barrett, ADT
    [J]. WEST NILE VIRUS: DETECTION, SURVEILLANCE, AND CONTROL, 2001, 951 : 262 - 271
  • [6] Arguments for live flavivirus vaccines
    de Silva, A
    Messer, W
    [J]. LANCET, 2004, 364 (9433): : 500 - 500
  • [7] A novel principle of attenuation for the development of new generation live flavivirus vaccines
    Koller, RM
    Heinz, FX
    Mandl, CW
    [J]. ARCHIVES OF VIROLOGY, 2004, : 191 - 200
  • [8] Recent advances in human flavivirus vaccines
    Scherwitzl, Iris
    Mongkolsapaja, Juthathip
    Screaton, Gavin
    [J]. CURRENT OPINION IN VIROLOGY, 2017, 23 : 95 - 101
  • [9] Bioinformatics in New Generation Flavivirus Vaccines
    Koraka, Penelope
    Martina, Byron E. E.
    Osterhaus, Albert D. M. E.
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [10] Using silica to stabilize flavivirus vaccines
    Demchenko, Diana
    Stedman, Kenneth
    Messer, William
    Lyski, Zoe
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257